Arturo Cesaro: First Meta-Analysis on the Vascular Protective Role of Semaglutide in PAD
Arturo Cesaro, Assistant Professor of Cardiology at University of Campania “Luigi Vanvitelli”, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“Just published in European Journal of Preventive Cardiology
Proud to share our newly published systematic review and meta-analysis evaluating the impact of semaglutide on peripheral artery disease (PAD)-related outcomes.
First meta-analysis focusing on PAD as a hard endpoint across randomized trials
Key takeaways
- Semaglutide was associated with a significant reduction in limb events
- Findings support a potential vascular protective role beyond coronary disease, extending to the peripheral circulation
A step forward in extending cardiometabolic prevention beyond the coronary circulation.
Huge thanks to all co-authors and collaborators for an outstandingy team effort.”
Title: Impact of semaglutide on limb events: a meta-analysis of randomized controlled trials
Authors: Arturo Cesaro, Vincenzo Acerbo, Miriam Longo, Alessandra Antonucci, Maria Ida Maiorino, Maria Grazia Monaco, Eugenio Martelli, Giorgio Giudice, Katherine Esposito, Francesco Giorgino, Massimo Federici, Paolo Calabrò
Read the Full Article on European Journal of Preventive Cardiology
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 16, 2026, 17:01Jeff Sternlicht: The Most Powerful Time to Lower Cholesterol Is Before Anyone Thinks You Need It
-
Mar 16, 2026, 16:14Siobhan Calafiore: Clinical Advantages of Apixaban Over Rivaroxaban in Reducing Bleeding Risk
-
Mar 16, 2026, 16:12Nuha El Sayed: Focused Summary of the 2026 ACC/AHA Guideline on Management of Dyslipidemia in Diabetes
-
Mar 16, 2026, 16:08Deepak Sudheendra: When a Vascular Looking Skin Pattern Isn’t Vascular
-
Mar 16, 2026, 16:06Surendra Karki։ Examining Blood Type and Coronary Heart Disease Risk in Australian Donors
-
Mar 16, 2026, 15:58Alan Nurden: Genome-Wide Analyses Unravel the Genetic Architecture of Coagulation and Fibrinolysis
-
Mar 16, 2026, 15:56Emmanuel J. Favaloro: Latest Publication from Sydney Centres on Heparin Therapy and Monitoring
-
Mar 16, 2026, 15:53Suvro Sankha Datta: Reporting Auto-Anti-Jk Antibodies in Children with Hematological Disorders
-
Mar 16, 2026, 15:44Francis Kynaston-Pearson: Why Randomised Controlled Trials Are the Gold Standard in Clinical Research